Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-3701
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics ; volume:7 ; number:1 ; day:25 ; month:10 ; year:2017 ; pages:1-14 ; date:12.2017
Cell & bioscience ; 7, Heft 1 (25.10.2017), 1-14, 12.2017
- Urheber
-
He, Mingqian
- Beteiligte Personen und Organisationen
-
Shi, Bingyin
SpringerLink (Online service)
- DOI
-
10.1186/s13578-017-0183-1
- URN
-
urn:nbn:de:1111-2017121814850
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- He, Mingqian
- Shi, Bingyin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Probiotics and microbiota composition
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Gut microbiota, probiotics and diabetes
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial
The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial
Probiotics and microbiota composition
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Gut microbiota, probiotics and diabetes
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial
The preterm gut microbiota and administration routes of different probiotics: a randomized controlled trial
Probiotics and microbiota composition
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Gut microbiota, probiotics and diabetes
Microbiota and neurologic diseases: potential effects of probiotics
Intestinal microbiota in human health and disease: the impact of probiotics
Effects of gut microbiota and probiotics on Alzheimer’s disease
Targeting the microbiome: from probiotics to fecal microbiota transplantation
Probiotics in human gut microbiota can degrade host glycosaminoglycans
Chrysanthemum morifolium Ramat extract and probiotics combination ameliorates metabolic disorders through regulating gut microbiota and PPARα subcellular localization
Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry
Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial